Cargando…

The progress of peptide vaccine clinical trials in gynecologic oncology

Peptide vaccine are a type of immunotherapy that are synthesized according to the amino acid sequence of known or predicted tumor antigen epitopes. They are safe and well tolerated and have shown exciting results in gynecologic oncology. However, no peptide vaccine has yet been licensed in this fiel...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mi, Cai, Jiang-Hui, Diao, Hao-Yang, Guo, Wen-Mei, Yang, Xiao, Xing, ShaSha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450897/
https://www.ncbi.nlm.nih.gov/pubmed/35687860
http://dx.doi.org/10.1080/21645515.2022.2062982
_version_ 1784784628167475200
author Tang, Mi
Cai, Jiang-Hui
Diao, Hao-Yang
Guo, Wen-Mei
Yang, Xiao
Xing, ShaSha
author_facet Tang, Mi
Cai, Jiang-Hui
Diao, Hao-Yang
Guo, Wen-Mei
Yang, Xiao
Xing, ShaSha
author_sort Tang, Mi
collection PubMed
description Peptide vaccine are a type of immunotherapy that are synthesized according to the amino acid sequence of known or predicted tumor antigen epitopes. They are safe and well tolerated and have shown exciting results in gynecologic oncology. However, no peptide vaccine has yet been licensed in this field. This review examines peptide vaccine clinical trials in gynecology registered on ClinicalTrials.gov through January 1, 2022, analyzes the global progress and current achievements of peptide vaccines in gynecology, and explores the efforts focused on devising new methods to boost immunotherapeutic outcomes, including the use of adjuvants, multi-epitope vaccines, combinations of helper T cell epitopes, personalized peptide vaccines, synthetic long peptides, new peptide delivery, and combination therapy.
format Online
Article
Text
id pubmed-9450897
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-94508972022-09-08 The progress of peptide vaccine clinical trials in gynecologic oncology Tang, Mi Cai, Jiang-Hui Diao, Hao-Yang Guo, Wen-Mei Yang, Xiao Xing, ShaSha Hum Vaccin Immunother Immunotherapeutics – Review Peptide vaccine are a type of immunotherapy that are synthesized according to the amino acid sequence of known or predicted tumor antigen epitopes. They are safe and well tolerated and have shown exciting results in gynecologic oncology. However, no peptide vaccine has yet been licensed in this field. This review examines peptide vaccine clinical trials in gynecology registered on ClinicalTrials.gov through January 1, 2022, analyzes the global progress and current achievements of peptide vaccines in gynecology, and explores the efforts focused on devising new methods to boost immunotherapeutic outcomes, including the use of adjuvants, multi-epitope vaccines, combinations of helper T cell epitopes, personalized peptide vaccines, synthetic long peptides, new peptide delivery, and combination therapy. Taylor & Francis 2022-06-10 /pmc/articles/PMC9450897/ /pubmed/35687860 http://dx.doi.org/10.1080/21645515.2022.2062982 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Immunotherapeutics – Review
Tang, Mi
Cai, Jiang-Hui
Diao, Hao-Yang
Guo, Wen-Mei
Yang, Xiao
Xing, ShaSha
The progress of peptide vaccine clinical trials in gynecologic oncology
title The progress of peptide vaccine clinical trials in gynecologic oncology
title_full The progress of peptide vaccine clinical trials in gynecologic oncology
title_fullStr The progress of peptide vaccine clinical trials in gynecologic oncology
title_full_unstemmed The progress of peptide vaccine clinical trials in gynecologic oncology
title_short The progress of peptide vaccine clinical trials in gynecologic oncology
title_sort progress of peptide vaccine clinical trials in gynecologic oncology
topic Immunotherapeutics – Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450897/
https://www.ncbi.nlm.nih.gov/pubmed/35687860
http://dx.doi.org/10.1080/21645515.2022.2062982
work_keys_str_mv AT tangmi theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT caijianghui theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT diaohaoyang theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT guowenmei theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT yangxiao theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT xingshasha theprogressofpeptidevaccineclinicaltrialsingynecologiconcology
AT tangmi progressofpeptidevaccineclinicaltrialsingynecologiconcology
AT caijianghui progressofpeptidevaccineclinicaltrialsingynecologiconcology
AT diaohaoyang progressofpeptidevaccineclinicaltrialsingynecologiconcology
AT guowenmei progressofpeptidevaccineclinicaltrialsingynecologiconcology
AT yangxiao progressofpeptidevaccineclinicaltrialsingynecologiconcology
AT xingshasha progressofpeptidevaccineclinicaltrialsingynecologiconcology